NCT02417246
Open-Labeled PK-PD Studies of Metoprolol ER
See it on ClinicalTrials.gov ↗36 people
47.2%
52.8%
17 womenmiddle line = equal numbers19 men
- Phase
- PHASE4
- Paid for by
- University of Florida
- Finished
- 2018-06-06
- Health conditions
- Blood Pressure
- Who could join
- Anyone
- Ages
- 18 Years – 120 Years
- Average age
- mean 53 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 30 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 63.9% · Black / African American 33.3% · Asian 2.8% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy or lactation”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnancy or lactation”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Renal insufficiency (serum creatinine greater than 1.5 in men or greater than 1.4 in women on screening laboratories)”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Known cardiovascular disease (including history of angina pectoris, myocardial infarction, coronary revascularization procedure, heart failure, or presence of a cardiac pacemaker)”
- No diabetes
Women with diabetes were turned away.
“Diabetes mellitus (Type 1 or 2) (defined as a diabetes diagnosis in the medical record or fasting blood glucose greater than or equal to 126 mg per dl or nonfasting blood glucose greater than or equal to 200 mg per dl on screening laborator…”
Study titles and rules are shown in their original English.